Ideal CSF inflammatory biomarkers should also have readily available assays with high accuracy and intermediate precision, and CSF changes relatively orthogonal to core AD biomarkers beta-amyloid 1–42 (Aβ42), total tau (t-Tau), and tau phosphorylated at threonine 181 (p-Tau181). This evidence concerns the gene MAPT and Alzheimer disease.